-
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
NCT07227532 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 22 Years and older ·
Sex: All (male and female)
· California: Fountain Valley, Ventura
-
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NCT06455098 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· California: Burlingame, La Jolla, Larkspur, Loma Linda
-
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
NCT07523750 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· California: Fountain Valley, Ventura
-
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
NCT07625215 ·
Phase: Phase 2 ·
Ages: 18 Years to 85 Years ·
Sex: All (male and female)
· California: San Francisco
-
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
NCT04045665 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Los Angeles, Stanford
-
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
NCT03968393 ·
Phase: Phase 4 ·
Ages: 55 Years and older ·
Sex: All (male and female)
· California: Los Angeles
-
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
NCT03907046 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Carmichael, Castro Valley, Colton, Downey
-
Applause Study I - Append System Early Feasibility Study
NCT07278869 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Los Angeles
-
BoxX-NoAF Clinical Trial
NCT06989775 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 65 Years and older ·
Sex: All (male and female)
· California: San Diego
-
COMparison of Physiological Algorithms for Real-time Evaluation of Atrial Fibrillation
NCT02997254 ·
Phase: Not specified ·
Ages: 21 Years to 90 Years ·
Sex: All (male and female)
· California: Stanford
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
NCT06959121 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 85 Years ·
Sex: All (male and female)
· California: St. Helena
-
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
NCT06784466 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· California: San Diego
-
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
NCT07298473 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: La Jolla, Los Angeles
-
Digitally Rendered Interventions And Knowledge To Limit Ethanol-Associated Atrial Fibrillation Severity
NCT06995391 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 21 Years and older ·
Sex: All (male and female)
· California: San Francisco
-
Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation
NCT07220525 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 21 Years and older ·
Sex: All (male and female)
· California: San Francisco
-
Esophageal Temperature During PVI Using Q-DOT Micro
NCT06392932 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Los Angeles
-
Full-Avoidance vs. Permissive/Regulated Drinking & Outcomes On Fibrillation
NCT06754176 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 21 Years and older ·
Sex: All (male and female)
· California: San Francisco
-
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)
NCT07308847 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· California: La Jolla, Sacramento
-
Incidence of Long-TeRm Atrial Fibrillation After Acute Illness
NCT07434674 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: La Jolla
-
Machine Learning in Atrial Fibrillation
NCT05371405 ·
Phase: Not specified ·
Ages: 22 Years to 80 Years ·
Sex: All (male and female)
· California: Stanford
-
Medtronic Terminate AF Study
NCT03546374 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Palo Alto, St. Helena
-
PVI Alone Versus PVI Plus PWI and SVCI With PFA
NCT07405359 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: San Francisco
-
Prevention of Postop Atrial Fibrillation Through Intraoperative Inducibility of Atrial Fibrillation and Amiodarone Treatment
NCT03868150 ·
Phase: Phase 4 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Stanford
-
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
NCT04088071 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Los Angeles, Santa Barbara, Ventura, Walnut Creek
-
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
NCT06735534 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Los Angeles, Oxnard, Stanford
-
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
NCT07175428 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Covina, Encinitas, Fremont, Huntington Beach
-
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
NCT07626411 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Fremont, La Jolla, Newport Beach, Northridge
-
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
NCT07430956 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Fremont, Huntington Beach, La Jolla, Pasadena
-
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
NCT05712200 ·
Phase: Phase 3 ·
Ages: 65 Years and older ·
Sex: All (male and female)
· California: Huntington Beach, Imperial, Lancaster, Loma Linda
-
The Dynamics of Human Atrial Fibrillation
NCT05366361 ·
Phase: Not specified ·
Ages: 22 Years to 80 Years ·
Sex: All (male and female)
· California: Stanford
-
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Fountain Valley, Loma Linda, Pasadena, Sacramento
-
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
NCT06324201 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Ventura
-
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
NCT05836987 ·
Phase: Phase 3 ·
Ages: 22 Years to 85 Years ·
Sex: All (male and female)
· California: Los Angeles, Sacramento, San Diego, San Francisco
-
Tracking Results of Ablations to Combat AF Registry Generation 2
NCT05111015 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: Loma Linda, St. Helena
-
Volunteers to Investigate Best Results for Ablation and Novel Therapies for Atrial Fibrillation
NCT05504356 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· California: San Francisco